Clearbridge Health Ltd. said it expects to report a significantly higher net loss for FY2025 based on a preliminary review of its unaudited results. The wider loss is mainly due to additional goodwill impairment and a fair value loss on convertible exchangeable bonds, both of which are non-cash items.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Clearbridge Health Ltd. published the original content used to generate this news brief via Singapore Exchange Limited (SGX) (Ref. ID: 3AWC1TSJ2L4MBHA5) on February 23, 2026, and is solely responsible for the information contained therein.